These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17557797)

  • 1. Odour identification test and its relation to cardiac 123I-metaiodobenzylguanidine in patients with drug induced parkinsonism.
    Lee PH; Yeo SH; Yong SW; Kim YJ
    J Neurol Neurosurg Psychiatry; 2007 Nov; 78(11):1250-2. PubMed ID: 17557797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 123I-MIBG cardiac uptake, smell identification and 123I-FP-CIT SPECT in the differential diagnosis between vascular parkinsonism and Parkinson's disease.
    Navarro-Otano J; Gaig C; Muxi A; Lomeña F; Compta Y; Buongiorno MT; Martí MJ; Tolosa E; Valldeoriola F
    Parkinsonism Relat Disord; 2014 Feb; 20(2):192-7. PubMed ID: 24252299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between cardiac 123I-MIBG and odor identification in patients with Parkinson's disease and multiple system atrophy.
    Lee PH; Yeo SH; Kim HJ; Youm HY
    Mov Disord; 2006 Nov; 21(11):1975-7. PubMed ID: 16960860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac 123I-MIBG scintigraphy in patients with drug induced parkinsonism.
    Lee PH; Kim JS; Shin DH; Yoon SN; Huh K
    J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):372-4. PubMed ID: 16103041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The status of olfactory function and the striatal dopaminergic system in drug-induced parkinsonism.
    Bovi T; Antonini A; Ottaviani S; Antonioli A; Cecchini MP; Di Francesco V; Bassetto MA; Zamboni M; Fiaschi A; Moretto G; Sbarbati A; Osculati F; Tinazzi M
    J Neurol; 2010 Nov; 257(11):1882-9. PubMed ID: 20635186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac sympathetic degeneration correlates with olfactory function in Parkinson's disease.
    Iijima M; Osawa M; Momose M; Kobayakawa T; Saito S; Iwata M; Uchiyama S
    Mov Disord; 2010 Jul; 25(9):1143-9. PubMed ID: 20131383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 123I-ioflupane brain SPECT and 123I-MIBG cardiac planar scintigraphy combined use in uncertain parkinsonian disorders.
    Nuvoli S; Spanu A; Piras MR; Nieddu A; Mulas A; Rocchitta G; Galleri G; Serra PA; Madeddu G
    Medicine (Baltimore); 2017 May; 96(21):e6967. PubMed ID: 28538394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of rCBF analysis in diagnosing Parkinson's disease: supplemental role with MIBG myocardial scintigraphy.
    Nagamachi S; Wakamatsu H; Kiyohara S; Fujita S; Futami S; Tamura S; Nakazato M; Yamashita S; Arita H; Nishii R; Kawai K
    Ann Nucl Med; 2008 Aug; 22(7):557-64. PubMed ID: 18756357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 123I-MIBG cardiac uptake and smell identification in parkinsonian patients with LRRK2 mutations.
    Valldeoriola F; Gaig C; Muxí A; Navales I; Paredes P; Lomeña F; De la Cerda A; Buongiorno M; Ezquerra M; Santacruz P; Martí MJ; Tolosa E
    J Neurol; 2011 Jun; 258(6):1126-32. PubMed ID: 21221623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olfactory deficits and cardiac 123I-MIBG in Parkinson's disease related to the LRRK2 R1441G and G2019S mutations.
    Ruiz-Martínez J; Gorostidi A; Goyenechea E; Alzualde A; Poza JJ; Rodríguez F; Bergareche A; Moreno F; López de Munain A; Martí Massó JF
    Mov Disord; 2011 Sep; 26(11):2026-31. PubMed ID: 21611983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive Olfactory Impairment and Cardiac Sympathetic Denervation in REM Sleep Behavior Disorder.
    Janzen A; Vadasz D; Booij J; Luster M; Librizzi D; Henrich MT; Timmermann L; Habibi M; Sittig E; Mayer G; Geibl F; Oertel W
    J Parkinsons Dis; 2022; 12(6):1921-1935. PubMed ID: 35754288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac [123I]metaiodobenzylguanidine scintigraphy for vascular Parkinsonism.
    Kim JS; Lee PH; Lee KS; Park JW; Kim YI; Chung YA; Kim SH; Kim SH; Kim J; Choi YY; Kim HT
    Mov Disord; 2006 Nov; 21(11):1990-4. PubMed ID: 16991157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased myocardial 123I-MIBG uptake in Parkinson's disease.
    Iwasa K; Nakajima K; Yoshikawa H; Tada A; Taki J; Takamori M
    Acta Neurol Scand; 1998 May; 97(5):303-6. PubMed ID: 9613559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SCOPA-AUT scale in different parkinsonisms and its correlation with (123) I-MIBG cardiac scintigraphy.
    Berganzo K; Tijero B; Somme JH; Llorens V; Sánchez-Manso JC; Low D; Iodice V; Vichayanrat E; Mathias CJ; Lezcano E; Zarranz JJ; Gómez-Esteban JC
    Parkinsonism Relat Disord; 2012 Jan; 18(1):45-8. PubMed ID: 21908227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Value of the Early Heart-to-Mediastinum Count Ratio in Cardiac 123I-mIBG Imaging for Parkinson's Disease.
    Frantellizzi V; Lavelli V; Ferrari C; Sardaro A; Farcomeni A; Pacilio M; Borrazzo C; Pani R; Rubini G; Vincentis G
    Curr Radiopharm; 2021; 14(1):64-69. PubMed ID: 32720610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olfactory dysfunction and cardiovascular dysautonomia in Parkinson's disease.
    Oka H; Toyoda C; Yogo M; Mochio S
    J Neurol; 2010 Jun; 257(6):969-76. PubMed ID: 20119648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptomatic Characteristics of Parkinson's Disease Induced by Neuroleptic Drugs, Based on a Functional Neuroimaging Diagnosis.
    Tachibana K; Matsuura K; Shindo A; Matsuyama H; Ii Y; Taniguchi A; Tomimoto H
    Intern Med; 2020; 59(4):485-490. PubMed ID: 32062624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is There Any Clinical Value of Adding 123I-Metaiodobenzylguanidine Myocardial Scintigraphy to 123I-Ioflupane (DaTscan) in the Differential Diagnosis of Parkinsonism?
    Stathaki M; Koukouraki S; Simos P; Boura I; Papadaki E; Bourogianni O; Tsaroucha A; Kapsoritakis N; Mitsias P; Spanaki C
    Clin Nucl Med; 2020 Aug; 45(8):588-593. PubMed ID: 32404715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of olfactory function factors with cardiac sympathetic denervation in Parkinson's disease.
    Ryu DW; Yoo SW; Choi KE; Oh YS; Kim JS
    J Neurol; 2024 Mar; 271(3):1397-1407. PubMed ID: 37940708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease.
    Courbon F; Brefel-Courbon C; Thalamas C; Alibelli MJ; Berry I; Montastruc JL; Rascol O; Senard JM
    Mov Disord; 2003 Aug; 18(8):890-7. PubMed ID: 12889078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.